Write For Us

Who Named the New COVID-19 Drug Bamlanivimab? | An Interview with Daniel Skovronsky

Sponsored Post Vitamin D2 Canada Persia
134 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named COVID-19 treatments. We also discussed the challenges of mass-producing antibodies and how medicine might change going forward.

Hosted by: Hank Green & Alexis Dahl

SciShow has a spinoff podcast! It's called SciShow Tangents. Check it out at http://www.scishowtangents.org
----------
Support SciShow by becoming a patron on Patreon: https://www.patreon.com/scishow
----------
Huge thanks go to the following Patreon supporters for helping us keep SciShow free for everyone forever:

Marwan Hassoun, Jb Taishoff, Bd_Tmprd, Harrison Mills, Jeffrey Mckishen, James Knight, Christoph Schwanke, Jacob, Matt Curls, Sam Buck, Christopher R Boucher, Eric Jensen, Lehel Kovacs, Adam Brainard, Greg, Ash, Sam Lutfi, Piya Shedden, KatieMarie Magnone, Scott Satovsky Jr, charles george, Alex Hackman, Chris Peters, Kevin Bealer
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Instagram: http://instagram.com/thescishow
----------
Sources:
https://www.istockphoto.com/vector/infographic-depicting-the-external-and-internal-coronavirus-structure-gm1202867079-345507611
https://www.istockphoto.com/vector/concepts-of-monoclonal-antibody-for-coronavirus-treatment-gm1279978172-378415156
Category
Science
Tags
SciShow, science, Hank
Sign in or sign up to post comments.
Be the first to comment